[The fibronectin level in patients with rheumatic heart defects undergoing cardiac surgical interventions].
Time course of serum fibronectin is investigated in cardiosurgical patients administered different immunocorrective treatments. The authors propose using fibronectin content as a prognostic criterion in this patient population during the postoperative period.
Dokunina
I L
IL
Siziakina
L P
LP
D015415:Biomarkers / Q000097:blood; D005353:Fibronectins / Q000097:blood*; D006801:Humans; D011184:Postoperative Period; D011379:Prognosis; D012214:Rheumatic Heart Disease / Q000097:blood* / Q000601:surgery; D018709:Statistics, Nonparametric
D015415:Biomarkers; D005353:Fibronectins